JANX·47103J105·US·equity·Healthcare - Biotechnology-Activist
JANX (JANUX THERAPEUTICS INC) is held by 107 institutional investors as of Q1 2026. Largest holders: RA CAPITAL MANAGEMENT, L.P. ($155.5M), BlackRock, Inc. ($75.5M), JANUS HENDERSON GROUP PLC ($58.3M). Net institutional sentiment: Mixed.
See how JANX's score breaks down across 4 SEC sources
Showing 1-20 of 119
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer